Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.
ConditionFertility Disorders
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorFairtility
About this trial
This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.
Eligibility criteria
Qualifiers
Women at least 18 years of age.
Embryos or eggs cultured in a time-lapse incubator connected to CHLOE Embryo Viewer.
Disqualifiers
Women with autologous eggs
Trial design
Treatments tested in this trial
- AI evaluation of oocytes.
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov